Jay S. Schneider, PhD
Professor of Pathology, Anatomy and Cell Biology, and Neurology at Thomas Jefferson University
Location: Philadelphia, Pennsylvania, United States
Jay S. Schneider, PhD, received his PhD from the State University of New York at Stony Brook and received postdoctoral training at the University of California, Los Angeles. Dr. Schneider leads basic and clinical research efforts on Parkinsonís disease at Thomas Jefferson University. His research focuses on the following areas: (i) understanding the pathophysiology of Parkinsonís disease and developing neuroprotective/neurorestorative therapies for the disease, (ii) development and evaluation of new treatments to alleviate motor symptoms of Parkinsonís disease, (iii) development of anti-dyskinesia therapies, (iv) understanding cognitive dysfunction in Parkinsonís disease and development of new treatments for cognitive dysfunction, and (v) exploration of an epigenetic basis for development of Parkinsonís disease. Dr. Schneider also oversees a number of clinical trials of new therapeutics for Parkinsonís disease.
- Inhibition of Striatal-enriched Phosphate (STEP) to Improve Parkinson-related Cognitive Dysfunction (2016)
- Inhibition of Striatal-Enriched Phosphatase (STEP) to Improve Parkinson-Related Cognitive Dysfunction (2014)
- Enzymatic Degradation of Brain Complex Gangliosides to Increase Endogenous GM1 Levels: Potential Neuroprotective/Neurorestorative Therapy for Parkinsonís disease (2012)